+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast 2026-2032- Product Image
5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

5-in-1 DTaP-Hib-IPV Vaccine Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138475
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The 5-in-1 DTaP-Hib-IPV Vaccine Market is projected to reach USD 1.13 Billion in 2026. It is expected to continue growing at a CAGR of 9.48%, reaching USD 1.94 Billion by 2032.

5-in-1 DTaP-Hib-IPV Vaccines: Executive Overview

5-in-1 DTaP-Hib-IPV vaccines combine protection against diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and poliomyelitis in a single pediatric formulation. Their public-health value is linked to reducing injection burden, simplifying immunization schedules, and supporting timely protection during early childhood. Adoption depends on national schedules, procurement systems, evidence requirements, cold-chain capacity, caregiver acceptance, and the availability of suitable combination-vaccine presentations.

Immunization Systems Are Shifting Toward Simpler, More Resilient Delivery

The vaccine landscape is being reshaped by efforts to improve routine coverage, recover missed childhood immunizations, and strengthen preparedness for outbreaks of vaccine-preventable diseases. Combination products can support these goals by reducing the number of clinic visits and injections, although their use must remain aligned with national schedules and product-label requirements. Health systems are also placing greater emphasis on reliable procurement, temperature-controlled distribution, safety monitoring, and equitable access in underserved communities.

Artificial Intelligence Supports Planning, Safety, and Program Execution

Artificial intelligence can contribute to this market through demand planning, inventory optimization, cold-chain monitoring, and identification of communities at risk of delayed vaccination. Analytics may also help health authorities detect unusual safety signals, improve appointment reminders, and target outreach while protecting personal health information. These applications require high-quality immunization records, transparent validation, human oversight, cybersecurity controls, and compliance with applicable health-data and medical-device regulations. AI can improve execution, but it does not replace clinical evaluation, regulatory review, or professional judgment.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America emphasizes established pediatric schedules, safety surveillance, and catch-up vaccination, while Latin America continues to focus on restoring routine coverage and addressing geographic and socioeconomic disparities. Europe combines strong regulatory and pharmacovigilance expectations with varied national procurement and schedule decisions. The Middle East places importance on continuity of childhood services amid population mobility and humanitarian pressures. Africa’s priorities include access, supply reliability, workforce capacity, and integration with broader immunization programs. Asia-Pacific presents diverse conditions, ranging from mature national systems to large rural populations requiring stronger last-mile delivery, local data systems, and community engagement.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Show Distinct Coordination Needs

ASEAN members face varied immunization infrastructures and benefit from regional cooperation on procurement, supply continuity, and cross-border disease control. BRICS countries encompass major differences in health-system capacity, domestic manufacturing, and public-program design, making harmonized evidence and resilient supply strategies important. The European Union operates within a shared regulatory environment while retaining national purchasing and schedule authority. G7 members generally have mature surveillance and delivery systems but must address hesitancy and access gaps. GCC countries often combine centralized public-health planning with substantial migrant populations. NATO members require continuity planning for civilian immunization services during emergencies, displacement, or infrastructure disruption.

Country Conditions Shape Scheduling, Procurement, and Delivery

Australia and Canada rely on coordinated public immunization programs across geographically dispersed populations. Brazil and Mexico must balance broad national coverage with regional inequities and catch-up needs. China and India operate at very large scale, making supply planning, local delivery capacity, and consistent recordkeeping central considerations. France, Germany, Italy, Spain, and the United Kingdom combine structured pediatric programs with country-specific recommendations, procurement arrangements, and safety-monitoring practices. Japan and South Korea emphasize high-quality routine services, careful schedule management, and public confidence. Russia’s priorities include continuity of supply, national program implementation, and surveillance. Across the United States, federal guidance interacts with state-level delivery, private providers, and public-program infrastructure.

Industry Leaders Should Align Product Design With Program Reality

Leaders should first map each target country’s schedule, procurement pathway, contraindication guidance, and requirements for interchangeability before prioritizing product development or access efforts. They should strengthen evidence packages covering immunogenicity, safety, coadministration, and real-world program performance, while investing in dependable manufacturing, quality systems, and cold-chain visibility. Partnerships with ministries, pediatric providers, community organizations, and international procurement channels can improve adoption and trust. Clear caregiver communication, rapid adverse-event response, and privacy-preserving analytics should accompany any digital or AI-enabled initiative. Success should be assessed through coverage, timeliness, missed-dose reduction, supply continuity, and equity indicators rather than product availability alone.

Methodology: Evidence-Led Assessment of Policy, Delivery, and Technology Factors

This executive summary uses a structured qualitative assessment of the 5-in-1 DTaP-Hib-IPV vaccine category. The analysis considers the antigens included, pediatric immunization-program requirements, public-health delivery conditions, regulatory and safety expectations, procurement and supply-chain factors, regional and country-level system differences, and potential applications of artificial intelligence. Findings are framed around verified principles of vaccination program implementation and do not rely on market estimates, market sizing, market shares, forecasts, or company-specific claims. Country and group observations are interpreted as contextual considerations rather than uniform conclusions.

Combination Vaccines Can Strengthen Childhood Immunization When Systems Are Ready

5-in-1 DTaP-Hib-IPV vaccines offer a practical way to reduce injection burden and support coordinated protection against five serious diseases. Their impact depends on fit with national schedules, dependable supply, trained delivery networks, trusted safety communication, and equitable access. The strongest strategies will combine sound clinical and regulatory evidence with resilient operations, context-specific partnerships, and responsible use of data and artificial intelligence. Leaders that treat the vaccine as part of an end-to-end immunization system will be better positioned to improve timely childhood protection.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Administration Route
7.1. Introduction
7.2. Intramuscular Injection
7.3. Subcutaneous Injection
8. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Dosage Form
8.1. Introduction
8.2. Freeze Dried
8.3. Liquid
9. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Packaging
9.1. Introduction
9.2. Multi Dose Vials
9.2.1. Five Dose Vials
9.2.2. Ten Dose Vials
9.3. Single Dose Prefilled Syringes
9.3.1. Glass Syringes
9.3.2. Plastic Syringes
10. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Age Group
10.1. Introduction
10.2. Children
10.3. Infants
10.4. Toddlers
11. 5-in-1 DTaP-Hib-IPV Vaccine Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Pediatric Clinics
11.3. Hospitals
11.3.1. Government Hospitals
11.3.2. Private Hospitals
11.4. Immunization Centers
12. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Distribution Channel
12.1. Introduction
12.2. Government Medical Stores
12.3. Hospital Pharmacies
12.3.1. Private Hospital Pharmacies
12.3.2. Public Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
12.5.1. Chain Pharmacies
12.5.2. Independent Pharmacies
13. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. 5-in-1 DTaP-Hib-IPV Vaccine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AstraZeneca plc
17.2. Baxter International Inc.
17.3. Bharat Biotech International Ltd.
17.4. Chongqing Zhifei Biological Products Co., Ltd.
17.5. CSL Limited
17.6. GlaxoSmithKline plc
17.7. Johnson & Johnson
17.8. Merck & Co., Inc.
17.9. Mitsubishi Tanabe Pharma Corporation
17.10. Novartis AG
17.11. Pfizer Inc.
17.12. Sanofi Pasteur
17.13. Serum Institute of India Pvt. Ltd.
17.14. Sinovac Biotech Ltd.
17.15. Takeda Pharmaceutical Company Limited
17.16. Wuhan Institute of Biological Products Co., Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global 5-in-1 DTaP-Hib-IPV Vaccine Market, Years Considered for the Study
FIGURE 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Market, Research Design
FIGURE 3. Global 5-in-1 DTaP-Hib-IPV Vaccine Market, Research Framework
FIGURE 4. Global 5-in-1 DTaP-Hib-IPV Vaccine Market, Data Triangulation
FIGURE 5. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 7. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 11. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 13. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Segmentation & Coverage
TABLE 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 4. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Subcutaneous Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Subcutaneous Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Subcutaneous Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 11. Global Freeze Dried Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Freeze Dried Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Freeze Dried Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 18. Global Multi Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Multi Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Multi Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Five Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Five Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Five Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Ten Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Ten Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Ten Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Single Dose Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Single Dose Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Single Dose Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Glass Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Glass Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Glass Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Plastic Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Plastic Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Plastic Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 37. Global Children Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Children Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Children Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Infants Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Infants Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Infants Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Toddlers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Toddlers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Toddlers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Pediatric Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Pediatric Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Pediatric Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Immunization Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Immunization Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Immunization Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. Global Government Medical Stores Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Government Medical Stores Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Government Medical Stores Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Private Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Private Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Private Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Public Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Public Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Public Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 107. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 109. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 110. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 111. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 112. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 113. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 114. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 116. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 117. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 119. North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 120. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 122. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 123. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 124. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 125. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 126. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 127. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 129. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 130. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 132. Latin America 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 133. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 135. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 136. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 137. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 138. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 139. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 140. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 142. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 143. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 145. Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 146. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 148. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 150. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 151. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 152. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 153. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 155. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 156. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 158. Middle East 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 159. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 161. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 162. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 163. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 164. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 165. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 166. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 168. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 169. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 171. Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 172. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 175. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 176. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 177. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 178. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 179. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 180. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 182. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 185. ASEAN 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 186. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 188. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 189. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 190. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 191. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 192. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 193. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 195. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 196. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 198. GCC 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 199. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 201. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 202. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 203. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 204. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 205. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 206. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 208. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 209. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 211. European Union 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 212. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 214. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 215. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 216. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 217. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 218. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 219. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 221. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 222. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 224. BRICS 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 225. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 227. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 228. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 229. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 230. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 231. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 232. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 234. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 235. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 237. G7 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 238. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 240. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 241. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 242. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 243. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 244. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 245. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 247. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 250. NATO 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 251. Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 252. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 253. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 254. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 255. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 256. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 257. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 258. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 259. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 261. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 262. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 264. United States 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 265. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 266. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 267. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 268. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 269. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 270. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 271. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 272. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 274. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 275. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 276. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 277. Canada 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 278. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 279. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 280. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 281. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 282. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 283. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 284. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 285. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 287. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 288. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 290. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 291. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 292. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 293. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 294. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 295. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 296. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 297. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 298. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 300. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 301. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 303. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 304. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 305. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 306. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 307. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 308. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 309. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 310. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 311. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 313. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 314. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 316. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 317. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 318. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 319. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 320. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 321. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 322. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Single Dose Prefilled Syringes, 2017-2032 (USD Million)
TABLE 323. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 324. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 326. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 327. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 328. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 329. Germany 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 330. France 5-in-1 DTaP-Hib-IPV Vaccine Market Size, 2017-2032 (USD Million)
TABLE 331. France 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 332. France 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 333. France 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 334. France 5-in-1 DTaP-Hib-IPV Vaccine Market Size, by Multi Dose Vials, 2017-2032 (USD Million)
TABLE 335. France 5-in-1 DTaP-Hib-IPV Va

Companies Mentioned

  • AstraZeneca plc
  • Baxter International Inc.
  • Bharat Biotech International Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • CSL Limited
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Takeda Pharmaceutical Company Limited
  • Wuhan Institute of Biological Products Co., Ltd.

Related Topics

Related Reports

Pertussis Vaccines Market - Global Strategic Business Report - Product Image

Pertussis Vaccines Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Pentacel Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Pentacel Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Tetanus Toxoid Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Tetanus Toxoid Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 114 Pages
  • Global
From
Respiratory Disease Vaccine Market Report 2026 - Product Image

Respiratory Disease Vaccine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • 265 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.